OUTCOME AND TOXICITY OF EXTENDED-FIELD INTENSITY MODULATED RADIOTHERAPY (EF-IMRT) IN LOCALLY ADVANCED CARCINOMA OF CERVIX – EXPERIENCE FROM TERTIARY CANCER CENTER

Author:

ANJAN BERA ,AVIK MAJI ,DEBJANI BANERJEE ,DEBOJYOTI MANNA ,SHILPI ADHIKARY

Abstract

Objectives: Whether to irradicate the para-aortic node prophylactically or not in locally advanced cervical carcinoma in the absence of para-aortic lymphadenopathy, the recommendation varies across guidelines. Extended field radiotherapy may improve overall survival (OS) by better local control of the para-aortic nodal region compared to pelvic RT alone, especially in patients unable to tolerate concurrent pelvic chemoradiotherapy. Methods: This was a single institutional retrospective study carried out in the department of radiotherapy at NRSMCH, Kolkata. A total of 30 HPE-proven locally advanced cervical cancer patients treated with extended field intensity-modulated radiotherapy (IMRT) were selected for this retrospective study. Results: Response assessment was done 12–16 weeks after completion of treatment and 26 patients (86%) had complete locoregional responses and four patients had the local disease (14%). The 2-year OS was 86%. The common toxicity was Grade I small bowel toxicity (diarrhea), skin reactions, and Grade I neutropenia, seen in 78%, 63%, and 58% of patients, respectively. Another acute toxicity was Grade I anemia seen in 35% of patients. The common late toxicity was Grade I lower GI (11%). Conclusions: Extended Field-IMRT is a convenient, feasible, and effective treatment modality for target coverage and para-aortic nodal control with minimal toxicity.

Publisher

Innovare Academic Sciences Pvt Ltd

Reference17 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 May;71(3):209-49. doi: 10.3322/caac.21660, PMID: 33538338

2. Chopra SJ, Mathew A, Maheshwari A, Bhatla N, Singh S, Rai B, et al. National cancer grid of India consensus guidelines on the management of cervical cancer. J Glob Oncol. 2018 Jul;4:1-15. doi: 10.1200/ JGO.17.00152, PMID: 30085891, PMCID: PMC6223405

3. Biswas L, Bera A, Manna D, Mondal S. Epidemiology of cervical cancer: A retrospective study in tertiary health-care center in Kolkata over one decade. Int J Med Sci Public Health. 2019 Nov;8:971-4. doi: 10.5455ijmsph.2019.0925914092019

4. Chopra S, Gupta M, Mathew A, Mahantshetty U, Engineer R, Lavanya G, et al. Locally advanced cervical cancer: A study of 5-year outcomes. Indian J Cancer. 2018 Jan-Mar;55(1):45-49. doi: 10.4103/ ijc.IJC_428_17, PMID: 30147092

5. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Cervical Cancer Version 1. Philadelphia, PA: National Comprehensive Cancer Network; 2023. Available from: https://www.nccn.org [Last accessed on 2023 May 16].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3